Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Preferred Shares (2021 - 2025)

Bioregenx (BRGX) has 5 years of Preferred Shares data on record, last reported at $4.0 in Q3 2025.

  • For Q3 2025, Preferred Shares changed 0.0% year-over-year to $4.0; the TTM value through Sep 2025 reached $4.0, changed 0.0%, while the annual FY2024 figure was $4.0, 0.0% changed from the prior year.
  • Preferred Shares reached $4.0 in Q3 2025 per BRGX's latest filing, roughly flat from $4.0 in the prior quarter.
  • Across five years, Preferred Shares topped out at $5000.0 in Q2 2023 and bottomed at $4.0 in Q4 2023.
  • Average Preferred Shares over 5 years is $1894.8, with a median of $4.0 recorded in 2023.
  • Peak YoY movement for Preferred Shares: changed 0.0% in 2022, then tumbled 99.92% in 2024.
  • A 5-year view of Preferred Shares shows it stood at $4900.0 in 2021, then changed by 0.0% to $4900.0 in 2022, then tumbled by 99.92% to $4.0 in 2023, then changed by 0.0% to $4.0 in 2024, then changed by 0.0% to $4.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Preferred Shares were $4.0 in Q3 2025, $4.0 in Q2 2025, and $4.0 in Q1 2025.